ERBB2 was more systematically analyzed in a sizable subset of childhood rhabdomyosarcoma tumors by Ganti et al. in 2006 [36] and in an even larger tumor series of 105 adult RMS patients by Armistead et al. in 2007 [37]. Here, ERBB2 is linked to rhabdomyosarcoma.